Impact of combined secondary prevention therapy after myocardial infarction: Data from a nationwide French registry
Authors:
- Nicolas DanchinNDNicolas Danchin
- Jean-Pierre CambouJCJean-Pierre Cambou
- Guy HananiaGHGuy Hanania
- Zena KadriZKZena Kadri
- Nathalie GenèsNGNathalie Genès
- Jean-Marc LablancheJLJean-Marc Lablanche
- Didier BlanchardDBDidier Blanchard
- Laurent VaurLVLaurent Vaur
- Pierre ClersonPCPierre Clerson
- Pascal GuéretPGPascal Guéret
- USIC 2000 investigatorsUIUSIC 2000 investigators
- 1 December 2005
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 150 (6) , 1147-1153
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Management and in-hospital outcome of patients with acute myocardial infarction admitted to intensive care units at the turn of the century: results from the French nationwide USIC 2000 registryHeart, 2004
- Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)The Lancet, 2003
- Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trialThe Lancet, 2003
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialThe Lancet, 2002
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk PatientsNew England Journal of Medicine, 2000
- Invited Commentary: Propensity ScoresAmerican Journal of Epidemiology, 1999
- beta Blockade after myocardial infarction: systematic review and meta regression analysisBMJ, 1999
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996